Marlies Eilers
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
Papers in
-
- Circular RNAs in diseases 2
- Histone Deacetylase Inhibitors Research 1
- RNA and protein synthesis mechanisms 1
- Wnt/β-catenin signaling in development and cancer 1
- Fibroblast Growth Factor Research 1
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 3
- Co-authors
- Vera Schäffer (8 shared papers)Brigitte Schlegelberger (8 shared papers)Britta Skawran (8 shared papers)Maria Sandbothe (4 shared papers)R. Buurman (3 shared papers)Florian Kühnel (3 shared papers)Engin Gürlevik (3 shared papers)Hans Kreipe (1 shared paper)
In The Last Decade
Marlies Eilers
8 papers receiving 335 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 212
- Molecular Biology 281
- Hepatology 22
- Oncology 41
- Pathology and Forensic Medicine 27
Countries citing papers authored by Marlies Eilers
This map shows the geographic impact of Marlies Eilers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlies Eilers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlies Eilers more than expected).
Fields of papers citing papers by Marlies Eilers
This network shows the impact of papers produced by Marlies Eilers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlies Eilers. The network helps show where Marlies Eilers may publish in the future.
Co-authors
The 25 scholars most cited alongside Marlies Eilers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 175 | |
| 2 | 2017 | 104 | |
| 3 | 2019 | 29 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 5 | |
| 8 | 2019 | 4 |
About Marlies Eilers
Marlies Eilers is a scholar working on Molecular Biology, Cancer Research, Oncology, Nutrition and Dietetics and Genetics, having authored 8 papers that have together received 336 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (2 papers), Trace Elements in Health (1 paper), Histone Deacetylase Inhibitors Research (1 paper), RNA and protein synthesis mechanisms (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (212 citations), Molecular Biology (281 citations), Hepatology (22 citations), Oncology (41 citations) and Pathology and Forensic Medicine (27 citations). Marlies Eilers has collaborated with scholars based in Germany, Denmark and Spain. Frequent co-authors include Vera Schäffer, Brigitte Schlegelberger, Britta Skawran, Maria Sandbothe, R. Buurman, Florian Kühnel, Engin Gürlevik, Hans Kreipe, Ludwig Wilkens and Thomas Illig. Their work appears in journals such as Journal of Cancer, Journal of Hepatology, European Journal of Human Genetics, Hepatology International and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.